Clinical Trials Logo

Near Vision clinical trials

View clinical trials related to Near Vision.

Filter by:

NCT ID: NCT06045299 Recruiting - Presbyopia Clinical Trials

Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Presbyopia

Start date: September 27, 2023
Phase: Phase 3
Study type: Interventional

Phase 3 Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Treatment of Presbyopia

NCT ID: NCT05753189 Completed - Presbyopia Clinical Trials

Phase 3 Safety Study for the Treatment of Presbyopia Subjects

Start date: February 21, 2023
Phase: Phase 3
Study type: Interventional

Safety Study of the Long-Term Safety of LNZ101 in Presbyopic Subjects

NCT ID: NCT05728944 Completed - Presbyopia Clinical Trials

Phase 3 Efficacy Study of LNZ101 for the Treatment of Presbyopia

CLARITY
Start date: April 24, 2023
Phase: Phase 3
Study type: Interventional

Phase 3 Efficacy Study to evaluate the Safety and Efficacy of LNZ101 for the Treatment of Presbyopia

NCT ID: NCT05656027 Completed - Presbyopia Clinical Trials

Phase 3 Evaluation of the Safety and Efficacy of LNZ101 for the Treatment of Presbyopia

CLARITY
Start date: December 19, 2022
Phase: Phase 3
Study type: Interventional

Phase 3 study to evaluate the safety and effectiveness of LNZ101 for the treatment of Presbyopia.

NCT ID: NCT05594537 Not yet recruiting - Cataract Clinical Trials

The Best Way to Improve the Near Visual Acuity After ZXR00 IOL Implantation

Start date: November 1, 2022
Phase:
Study type: Observational

The Best Way to Improve the Near Visual Acuity After ZXR00 IOL Implantation

NCT ID: NCT05564832 Recruiting - Near Vision Clinical Trials

Pharmacological Treatment of Presbyopia

Start date: August 1, 2022
Phase: Early Phase 1
Study type: Interventional

In this clinical trial, a total of 75 presbyopic patients in the age range of 40 to 60 years old will be participated. The right eyes of 45 patients will be treated by Biocarpine® and they will be considered as the case group, their left eyes will be defined as the controls. In another case group, the right eyes of 30 patients will received Vuity® eye drops and their left eyes will be considered as controls.

NCT ID: NCT05431543 Completed - Presbyopia Clinical Trials

Evaluation of the Safety and Effectiveness of Aceclidine (LNZ101) and Aceclidine + Brimonidine (LNZ100) in the Treatment of Presbyopia

Start date: August 6, 2022
Phase: Phase 2
Study type: Interventional

To evaluate the safety and effectiveness of Aceclidine/Brimonidine (LNZ101) compared with Aceclidine (LNZ100) and vehicle in the treatment of Presbyopia.

NCT ID: NCT05359380 Completed - Cataract Clinical Trials

The Impact of Light Conditions on the Efficacy of Multifocal Intraocular Lens Implantation in Activities of Daily Living

Start date: September 15, 2021
Phase:
Study type: Observational [Patient Registry]

Primary objective of this study is to identify the optimal task lighting conditions (in terms of light intensity and light temperature) for 10 activities of daily living (ADLs) that require near or intermediate vision acuity in a validated ADL simulation framework for a sample of patients who underwent presbyopic correction with bilateral multifocal intraocular lenses (IOLs) implantation, and to compare their capacity to perform ADLs (ADL scores) between three study groups (SG): SG1. patients implanted bilaterally with trifocal diffractive IOLs, SG2. patients implanted bilaterally with bifocal hybrid (diffractive-refractive) IOLs, SG3. patients implanted bilaterally with monofocal IOLs

NCT ID: NCT05005624 Completed - Presbyopia Clinical Trials

Validation of an Activities-of-daily-living Framework at Different Light Conditions

Start date: July 1, 2020
Phase:
Study type: Observational

Primary objective of this study is the construction and validation of an experimental environment for the simulation of a variety of near- and intermediate-vision activities of daily living (ADLs) in different combinations of light temperature and light intensity.

NCT ID: NCT04907955 Completed - Visual Impairment Clinical Trials

Visual Performance Following Implantation of Presbyopia Correcting IOLs

Start date: June 1, 2019
Phase: N/A
Study type: Interventional

The purpose of the current study was to compare the visual performance after bilateral implantation of the Panoptix IOL , or the AT LISA IOL or Tecnis Symfony IOL . The focus was on intermediate vision, defocus curves, and contrast sensitivity.